Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

16.36 

0.41 2.6%

as of Aug 16 '19

52 Week Range:

12.88 18.14


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, acne, rosacea, and psoriasis; and central nervous system, cardiovascular, and gastrointestinal diseases. Its strategic brands include ACTIKERALL, BALNEUM, DECODERM, SATIVEX, SKILARENCE, and DECODERM. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases, as well as drug discovery partnership with X-Chem, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 5.26
4.52
4.93
5.15
5.42
5.14
growth rate -14.1% 9.1% 4.5% 5.2% -5.2%
Earnings BIT 144.72
171.50
119.20
71.97
48.82
7.18
-8.63
92.83
86.17
-53.81
56.73
growth rate 18.5% -30.5% -39.6% -32.2% -85.3% -100.0% 100.0% -7.2% -100.0% 100.0%
Avg.PE 6.71
10.02
9.61
10.48
16.47
-24.78
37.46
-18.05
34.53
growth rate 49.3% -4.1% 9.1% 57.2% -100.0% 100.0% -100.0% 100.0%
ROA 9.60
10.50
7.90
5.60
5.40
-2.20
growth rate 9.4% -24.8% -29.1% -3.6% -100.0%
ROE 22.20
21.60
15.10
10.10
8.60
-3.70
growth rate -2.7% -30.1% -33.1% -14.9% -100.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 83.42
97.66
84.62
88.14
80.84
137.57
265.65
188.57
176.15
147.41
231.68
growth rate 17.1% -13.4% 4.2% -8.3% 70.2% 93.1% -29.0% -6.6% -16.3% 57.2%
Acct.Payable 198.39
218.16
225.31
237.26
140.60
191.02
growth rate 10.0% 3.3% 5.3% -40.7% 35.9%
Cur.Assets 435.33
503.99
528.07
458.66
310.44
334.60
1,107.27
1,147.08
738.55
515.36
414.37
growth rate 15.8% 4.8% -13.1% -32.3% 7.8% 230.9% 3.6% -35.6% -30.2% -19.6%
Total Assets 1,396.40
1,483.00
1,536.70
1,456.60
1,356.10
1,772.72
2,540.40
2,532.35
2,818.53
2,176.45
2,389.51
growth rate 6.2% 3.6% -5.2% -6.9% 30.7% 43.3% -0.3% 11.3% -22.8% 9.8%
Cash 186.10
259.70
62.50
38.70
52.30
80.86
297.93
597.95
249.50
211.54
85.19
growth rate 39.6% -75.9% -38.1% 35.1% 54.6% 268.5% 100.7% -58.3% -15.2% -59.7%
Inventory 112.53
97.70
87.90
93.21
92.41
97.74
81.02
87.12
91.04
83.74
92.33
growth rate -13.2% -10.0% 6.0% -0.9% 5.8% -17.1% 7.5% 4.5% -8.0% 10.3%
Cur.Liabilities 307.92
307.82
361.58
413.56
249.48
398.08
361.19
301.56
371.59
348.41
244.07
growth rate 0.0% 17.5% 14.4% -39.7% 59.6% -9.3% -16.5% 23.2% -6.2% -30.0%
Liabilities 743.40
1,483.00
717.40
601.90
432.40
884.39
1,200.84
1,069.76
1,298.25
1,042.77
1,197.76
growth rate 99.5% -51.6% -16.1% -28.2% 104.5% 35.8% -10.9% 21.4% -19.7% 14.9%
LT Debt 321.00
265.70
149.10
0.00
0.00
267.23
331.99
333.01
331.13
262.65
555.54
growth rate -17.2% -43.9% -100.0% 24.2% 0.3% -0.6% -20.7% 111.5%
Equity 653.00
751.00
819.30
854.70
923.70
888.33
1,339.57
1,462.58
1,520.28
1,133.68
1,191.75
growth rate 15.0% 9.1% 4.3% 8.1% -3.8% 50.8% 9.2% 3.9% -25.4% 5.1%
Common Shares 124.22
166.10
166.10
166.10
170.52
20.75
20.75
20.75
20.75
20.75
20.86
growth rate 33.7% 0.0% 0.0% 2.7% -87.8% 0.0% 0.0% 0.0% 0.0% 0.5%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 0.00
0.00
13.60
18.70
0.00
14.60
40.15
12.51
24.37
18.79
13.38
growth rate 37.5% -100.0% 175.1% -68.8% 94.8% -22.9% -28.8%
Cash Dividends 52.50
52.50
55.10
47.40
1.20
0.83
35.00
35.00
33.00
33.00
22.69
growth rate 0.0% 5.0% -14.0% -97.5% -31.2% 4,137.3% 0.0% -5.7% 0.0% -31.2%
Cash From OA 233.10
261.60
174.60
100.10
112.80
67.11
646.94
170.88
105.06
6.09
143.21
growth rate 12.2% -33.3% -42.7% 12.7% -40.5% 863.9% -73.6% -38.5% -94.2% 2,250.0%
FCF 0.00
0.00
81.60
61.70
33.10
52.52
606.79
158.37
80.68
-12.69
129.83
growth rate -24.4% -46.4% 58.7% 1,055.4% -73.9% -49.1% -100.0% 100.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 902.80
925.50
882.40
873.10
682.90
825.48
827.64
737.53
822.29
676.92
758.52
growth rate 2.5% -4.7% -1.1% -21.8% 20.9% 0.3% -10.9% 11.5% -17.7% 12.1%
Op.Income 165.73
179.12
154.40
77.30
53.45
7.18
-8.63
92.83
86.17
-53.81
56.73
growth rate 8.1% -13.8% -49.9% -30.9% -86.6% -100.0% 100.0% -7.2% -100.0% 100.0%
IBT 144.70
171.50
119.20
72.00
48.90
-89.73
481.98
172.64
92.64
-321.06
74.97
growth rate 18.5% -30.5% -39.6% -32.1% -100.0% 100.0% -64.2% -46.3% -100.0% 100.0%
Net Income 136.10
151.50
118.60
84.20
76.40
-33.72
448.43
131.83
75.48
-303.96
77.67
growth rate 11.3% -21.7% -29.0% -9.3% -100.0% 100.0% -70.6% -42.7% -100.0% 100.0%
EPS 0.82
0.91
0.71
0.51
0.45
-0.19
growth rate 11.0% -22.0% -28.2% -11.8% -100.0%
Gross Profit 569.40
580.90
608.70
639.70
420.70
631.08
632.43
571.38
644.91
488.03
566.47
growth rate 2.0% 4.8% 5.1% -34.2% 50.0% 0.2% -9.7% 12.9% -24.3% 16.1%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 9.67
7.74
14.33
39.90
11.91
growth rate -20.0% 85.2% 178.5% -70.2%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 138.37
159.50
231.68
250.40
325.21
growth rate 15.3% 45.3% 8.1% 29.9%
Acct.Payable 154.70
191.02
331.30
250.52
growth rate 11.1% 73.4% -24.4%
Cur.Assets 295.19
382.60
414.37
452.10
528.27
growth rate 29.6% 8.3% 9.1% 16.9%
Total Assets 1,959.94
2,422.50
2,389.51
2,465.10
2,512.01
growth rate 23.6% -1.4% 3.2% 1.9%
Cash 57.17
67.80
85.19
43.70
34.94
growth rate 18.6% 25.7% -48.7% -20.0%
Inventory 88.79
96.30
92.33
97.80
100.12
growth rate 8.5% -4.1% 5.9% 2.4%
Cur.Liabilities 258.43
237.60
244.07
331.30
382.73
growth rate -8.1% 2.7% 35.7% 15.5%
Liabilities 804.13
1,219.90
1,197.76
1,237.50
1,281.91
growth rate 51.7% -1.8% 3.3% 3.6%
LT Debt 111.54
550.30
555.54
529.70
544.87
growth rate 393.4% 1.0% -4.7% 2.9%
Equity 1,155.81
1,202.60
1,191.75
1,227.60
1,230.10
growth rate 4.1% -0.9% 3.0% 0.2%
Common Shares 20.86
1,202.60
20.86
1,227.60
20.95
growth rate 5,664.6% -98.3% 5,784.4% -98.3%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 2.70
5.80
3.08
3.60
0.08
growth rate 114.4% -47.0% 17.1% -97.9%
Cash Dividends 22.69
0.01
24.15
24.15
24.15
growth rate -100.0% 241,390.0% 0.0% 0.0%
Cash From OA 35.94
32.06
41.31
28.50
79.46
growth rate -10.8% 28.8% -31.0% 178.8%
FCF 33.23
26.27
38.23
24.90
79.39
growth rate -21.0% 45.6% -34.9% 218.8%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 178.38
173.72
217.12
224.40
208.56
growth rate -2.6% 25.0% 3.4% -7.1%
Op.Income 9.67
7.74
14.33
39.90
11.91
growth rate -20.0% 85.2% 178.5% -70.2%
IBT 22.16
43.54
-27.83
42.40
31.22
growth rate 96.5% -100.0% 100.0% -26.4%
Net Income 21.09
41.21
-15.53
29.90
32.04
growth rate 95.4% -100.0% 100.0% 7.2%
EPS
growth rate
Gross Profit 154.37
87.34
194.07
164.20
179.99
growth rate -43.4% 122.2% -15.4% 9.6%
R&D -18.60
57.40
-57.40
21.70
-21.70
growth rate 100.0% -100.0% 100.0% -100.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (0.00)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 32.46 32.46 30.30
EPS / Growth 16.5% 0.50 11.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.6% 9.8% 9.8%
Future PE 3.14 27.42 27.42
Future EPS 0.59 1.28 1.28
Value Price
MOS %
0.46
-97.2%
8.66
-47.1%
8.66
-47.1%
MOS Price 0.23 4.33 4.33
IRT 26.10 14.57 14.57

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.